Literature DB >> 28477746

Systematic review and meta-analysis of local resection or transanal endoscopic microsurgery versus radical resection in stage i rectal cancer: A real standard?

Geneviève Veereman1, Joan Vlayen1, Jo Robays1, Nicolas Fairon1, Sabine Stordeur1, Christian Rolfo2, Didier Bielen3, Alain Bols4, Pieter Demetter5, André D'hoore6, Karin Haustermans7, Alain Hendlisz8, Arnaud Lemmers9, Daniel Leonard10, Freddy Penninckx6, Eric Van Cutsem11, Marc Peeters12.   

Abstract

Current guidelines recommend radical resection for stage I rectal cancer. However, since screening programs are being installed, an increasing number of cancers are being detected in early stages. Endoscopic resection is often performed at the time of diagnosis. This systematic review was undertaken to review the evidence on endoscopic approach vs. radical resection for stage I rectal cancer. Recommendations were issued based on the GRADE methodology and risk stratification used in clinical practice. A systematic search (until March 2015) identified 2 meta-analyses and 1 additional randomized trial. For the primary outcomes (overall survival, disease-free survival, local recurrence-free survival and metastasis-free survival) no evidence could be found on the superiority of local or radical resection. Secondary outcomes (blood loss, hospital stay, operative time, number of permanent stomas and perioperative deaths) were in favour of local resection. The authors strongly recommend radical resection for T2 rectal cancer, but consider 'en bloc' local resection sufficient for pT1 sm1 rectal cancers when confirmed pathologically. Discussion by a multidisciplinary team and adequate surveillance remain mandatory.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; Rectum; Resection; Stage I; Surgery; Total mesorectal excision; Transanal endoscopic microsurgery; Transanal excision

Mesh:

Year:  2017        PMID: 28477746     DOI: 10.1016/j.critrevonc.2017.03.008

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  11 in total

1.  Do Stage I Colorectal Cancers with Lymphatic Invasion Require a Different Postoperative Approach?

Authors:  Lieve G J Leijssen; Anne M Dinaux; Hiroko Kinutake; Liliana G Bordeianou; David L Berger
Journal:  J Gastrointest Surg       Date:  2018-12-03       Impact factor: 3.452

2.  Rectal cancer confined to the bowel wall: the role of 3 Tesla phased-array MR imaging in T categorization.

Authors:  Hale Çolakoğlu Er; Elif Peker; Ayşe Erden; İlhan Erden; Ethem Geçim; Berna Savaş
Journal:  Br J Radiol       Date:  2017-11-21       Impact factor: 3.039

3.  Postoperative Outcomes of Screen-Detected vs Non-Screen-Detected Colorectal Cancer in the Netherlands.

Authors:  Michael P M de Neree Tot Babberich; Nina C A Vermeer; Michel W J M Wouters; Wilhelmina M U van Grevenstein; Koen C M J Peeters; Evelien Dekker; Pieter J Tanis
Journal:  JAMA Surg       Date:  2018-12-19       Impact factor: 14.766

Review 4.  Multidisciplinary management of elderly patients with rectal cancer: recommendations from the SICG (Italian Society of Geriatric Surgery), SIFIPAC (Italian Society of Surgical Pathophysiology), SICE (Italian Society of Endoscopic Surgery and new technologies), and the WSES (World Society of Emergency Surgery) International Consensus Project.

Authors:  Mauro Podda; Patricia Sylla; Gianluca Baiocchi; Michel Adamina; Vanni Agnoletti; Ferdinando Agresta; Luca Ansaloni; Alberto Arezzo; Nicola Avenia; Walter Biffl; Antonio Biondi; Simona Bui; Fabio C Campanile; Paolo Carcoforo; Claudia Commisso; Antonio Crucitti; Nicola De'Angelis; Gian Luigi De'Angelis; Massimo De Filippo; Belinda De Simone; Salomone Di Saverio; Giorgio Ercolani; Gustavo P Fraga; Francesco Gabrielli; Federica Gaiani; Mario Guerrieri; Angelo Guttadauro; Yoram Kluger; Ari K Leppaniemi; Andrea Loffredo; Tiziana Meschi; Ernest E Moore; Monica Ortenzi; Francesco Pata; Dario Parini; Adolfo Pisanu; Gilberto Poggioli; Andrea Polistena; Alessandro Puzziello; Fabio Rondelli; Massimo Sartelli; Neil Smart; Michael E Sugrue; Patricia Tejedor; Marco Vacante; Federico Coccolini; Justin Davies; Fausto Catena
Journal:  World J Emerg Surg       Date:  2021-07-02       Impact factor: 5.469

5.  Combination of carcinoembryonic antigen with the American Joint Committee on Cancer TNM staging system in rectal cancer: a real-world and large population-based study.

Authors:  Qi Liu; Peng Lian; Dakui Luo; Sanjun Cai; Qingguo Li; Xinxiang Li
Journal:  Onco Targets Ther       Date:  2018-09-13       Impact factor: 4.147

6.  Transanal endoscopic microsurgery for rectal lesions in a specialist regional early rectal cancer centre: the Mersey experience.

Authors:  M Ondhia; P Tamvakeras; P O'Toole; A Montazerri; T Andrews; C Farrell; S Ahmed; S Slawik; S Ahmed
Journal:  Colorectal Dis       Date:  2019-07-01       Impact factor: 3.788

7.  Total Mesorectal Excision vs. Transanal Endoscopic Microsurgery Followed by Radiotherapy for T2N0M0 Distal Rectal Cancer: A Multicenter Randomized Trial.

Authors:  Junwei Tang; Yue Zhang; Dongsheng Zhang; Chuan Zhang; Kangpeng Jin; Dongjian Ji; Wen Peng; Yifei Feng; Yueming Sun
Journal:  Front Surg       Date:  2022-02-01

Review 8.  Transanal endoscopic microsurgery: exploring its indications and novel applications. A narrative review.

Authors:  Xiaoqiang Xue; Guole Lin
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2021-09-01       Impact factor: 1.195

9.  Management of Low Rectal Cancer Complicating Ulcerative Colitis: Proposal of a Treatment Algorithm.

Authors:  Bruno Sensi; Giulia Bagaglini; Vittoria Bellato; Daniele Cerbo; Andrea Martina Guida; Jim Khan; Yves Panis; Luca Savino; Leandro Siragusa; Giuseppe S Sica
Journal:  Cancers (Basel)       Date:  2021-05-13       Impact factor: 6.639

10.  A 10-Year Evaluation of Short-Term Outcomes After Synchronous Colorectal Cancer Surgery: a Dutch Population-Based Study.

Authors:  A K Warps; R Detering; J W T Dekker; R A E M Tollenaar; P J Tanis
Journal:  J Gastrointest Surg       Date:  2021-05-24       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.